Responses
New players and novel targets in inflammation
02.21 Inhibition effects of rosiglitazone, pparγ agonist, on migration and invasion of rheumatoid arthritis-fibroblast like synoviocyte (fls) by down regulating cyr61
Compose a Response to This Article
Other responses
No responses have been published for this article.